Clinical Proof-of-Concept for CED: Lessons from Protein-Based & AAV Gene Therapies
Time: 11:00 am
day: Day Two - Morning - Track B
Details:
- Clinical progress in CNS delivery of protein-based (antibodies, albumin-sized) and AAV gene therapies, with a brief overview of liposomal approaches
- Delivery challenges and strategies for effective CNS penetration and therapeutic targeting
- Regulatory considerations and pathways shaping clinical approval
